Buprenorphine, oxycodone, hydrocodone, and methadone mortality in the United States (2010‒2017).

ABSTRACT:

Objective

Opioid overdose survivors present to emergency departments (EDs) and many EDs have developed programs to initiate buprenorphine. The impact of the increasing use of buprenorphine in ED and by other providers is unknown while opioid mortality continues to rise. Public mortality data do not distinguish buprenorphine from other prescription opioids. Our objective was to determine when changes in overdose mortality trends occurred comparing deaths involving buprenorphine to oxycodone, hydrocodone, and methadone.

Methods

This observational study utilized the drug-involved mortality database including US death certificates (2010‒2017) in which buprenorphine, oxycodone, hydrocodone, or methadone were contributing causes of death (determined through textual analysis). Popu

SUBMITTER: Rockhill KM 

PROVIDER: S-EPMC11499299 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature